LSL Pharma Group Inc's total assets for Q3 2024 were $37.96M, an increase of 2.72% from the previous quarter. TSE:LSL total liabilities were $17.59M for the fiscal quarter, a 0.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.